CD4 and Chagas disease: Therefore, Th17-primed (and thus IL-21-primed) CD8+ T cells may offer several advantages over Th1-primed CD8+ T cells in the course of T. cruzi infection, making Th17 cells a highly relevant CD4+ T cell subset to target during the development of vaccines for Chagas disease, and perhaps for other pathogens.